How we wish to be cited:
Norberg B. Confessions of a skeptic [health]. Rondel 2002; 14. URL:
http://www.rondellen.net
I am looking at a blond beauty, 55 years of age, looks like 35, a professional leader and executive, length 160 cm, weight 49 kg, jogs 5 km in 20 minutes. I imagine that a modification of your hasty style of life would be more efficient than Artrox.
Too much work, too much "relaxation", too monotonous movements may promote trouble from joints, tendons, and muscles. The weakest link of a chain is prone to break, when tested. I imagine that less work, less jogging, a little swimming, a little climbing would reduce the pain in your knees and shoulders.
Your comparison with cobalamin (vitamin B12) and folate is not entirely to the point. Deficiency of these vitamins is associated with lesions of nerve cells, bone marrow cells, and the cells of mucous membranes and reproduction. These cell systems are healed by vitamin therapy. Untreated deficiencies are fatal. These observations have been repeated on millions of cases (1).
I am aware that Artrox has some scientific documentation for reducing the pain of worn joints (2-4). Furthermore, I am aware of the fact that glucosamine, the active substance of Artrox, is almost free of side effects and toxicity, in contrast to most other analgesic drugs. Nevertheless, I would like you to suit your workload within your biological frames.
For a woman in your position, Maya, the cost of Artrox is negligible, one US dollar twice a day until pain relief. Within a few weeks, the dose and cost is reduced to one dollar a day, provided that the desired pain reduction is obtained.
In contrast to common conceptions, the classification of glucosamine as a drug made it cheaper in Sweden. During 2001, Swedish sales were about 1-2 billions of US dollars. The patient cost of a daily dose could be 6 dollars. Now sales are expected to decrease to 10-20 millions, a cost reduction by 99%. No patient is recommended a more expensive dose than about 2 dollars a day.
I know that the dealers in supplements have advertised another message. They had to sell off their stock of glucosamine during 2002. Thus, the supplementers appeared to be cheaper than the pharmacies during a transitional period (cf 5, 6).
Pardon, Maya! You are right! This is just background information for physicians and scientists. Here, your prescription for Artrox! You are welcome!
Bo Norberg
References
Published November 24, 2002